CAS
BIIB icon

Coppell Advisory Solutions’s Biogen BIIB Stock Holding History

Coppell Advisory Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7
Closed -$1.05K – 487
2024
Q4 		$1.05K Buy
7
+2
+40% +$337 ﹤0.01% 1657
2024
Q3 		$973 Hold
5
– – ﹤0.01% 1580
2024
Q2 		$1.16K Buy
+5
New +$1.09K ﹤0.01% 1482

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coppell Advisory Solutions's BIIB Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Biogen (BIIB) in Q1 2025, closing a stake of 7 shares — an estimated $1.05K sold.

Coppell Advisory Solutions first reported a position in BIIB in Q2 2024 and held it in 3 quarters. The position peaked at $1.16K in Q2 2024. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 7 Biogen shares in Q1 2025, an estimated $1.05K.
  • Coppell Advisory Solutions first reported a position in Biogen in Q2 2024 and held it in 3 quarters.
  • Coppell Advisory Solutions's Biogen position peaked at $1.16K in Q2 2024.
  • 883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.